Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid TumorsJesús García‐Foncillas, Sebastian Stintzing, Philippe Ronga et al.|Frontiers in Oncology|2019Cited by 199
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket StudyYoshiaki Nakamura, Tanios Bekaii‐Saab, Nobumasa Mizuno et al.|Journal of Clinical Oncology|2023Cited by 100